IQVIA HOLDINGS INC.
Ticker: IQVIndustrialsProfessional ServicesS&P 500The business
IQVIA Holdings Inc. (NYSE: IQV) is a leading global provider of clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries. The company operates at www.iqvia.com and serves as a critical partner throughout the pharmaceutical development and commercialization lifecycle.
IQVIA maintains one of the largest and most comprehensive collections of healthcare information globally, encompassing more than 1.2 billion comprehensive, longitudinal, unique non-identified patient records. The company's proprietary data set spans approximately 68 petabytes of information sourced from approximately 150,000 data suppliers and covering over one million data feeds worldwide. This information foundation enables IQVIA to deliver insights on approximately 90 percent of the world's pharmaceuticals by sales volume.
The company operates through three reportable segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. Effective January 1, 2026, the company reorganized into Commercial Solutions and Research & Development Solutions segments. Technology & Analytics Solutions provides cloud-based SaaS applications, real-world evidence platforms, analytics and consulting services, and information offerings across more than 100 countries. Research & Development Solutions delivers clinical trial support, laboratory services, patient recruitment, and strategic planning capabilities. Contract Sales & Medical Solutions offers healthcare provider engagement, patient engagement programs, and medical services to support product commercialization.
IQVIA employs approximately 89,000 people across more than 100 countries, including over 31,000 Technology & Analytics Solutions employees, approximately 51,000 Research & Development Solutions employees, and approximately 7,000 Contract Sales & Medical Solutions employees. The company serves a diversified client base exceeding 10,000 customers, with nearly all of the top 100 global pharmaceutical and biotechnology companies as clients. No single client represents more than 10 percent of total revenues.
The company addresses a market opportunity estimated at approximately $335 billion, consisting of outsourced research and development, real-world evidence and connected health, and technology-enabled clinical and commercial operations markets. IQVIA's competitive advantages include its proprietary healthcare data infrastructure, advanced analytics capabilities, global presence, domain expertise, and integrated service offerings that enable clients to reduce development timelines and improve operational efficiency.
- Sector
- Industrials
- Industry
- Professional Services
- HQ
- DURHAM, NC
- FY end
- 12-31
- CIK
- 1478242
- SIC
- 8731
Ownership
Who holds IQVIA HOLDINGS INC. — across funds, superinvestors and bonds · N-PORT 2026Q2 · 13F 2026-06-30
Top fund holders
| Fund | % of fund | Value |
|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VTI · VANGUARD INDEX FUNDS | 0.04% | $1.02B |
| VANGUARD 500 INDEX FUND VOO · VANGUARD INDEX FUNDS | 0.05% | $835.37M |
| VANGUARD MID-CAP INDEX FUND VO · VANGUARD INDEX FUNDS | 0.31% | $698.77M |
| Oakmark Select Fund OAKLX · HARRIS ASSOCIATES INVESTMENT TRUST | 6.05% | $503.43M |
| Oakmark Fund OAKMX · HARRIS ASSOCIATES INVESTMENT TRUST | 2.06% | $495.67M |
Superinvestors in IQVIA HOLDINGS INC.
Share of each manager's reported 13F portfolio.
Bonds held by funds
Funds report holding 8 issues of IQVIA HOLDINGS INC.'s debt, $2.31B at fund-held market value — what funds hold, not the company's debt outstanding. Weighted-average coupon 5.79%, maturing 2026–2033.
| Issue | Coupon | Matures | Funds | Fund-held |
|---|---|---|---|---|
| IQVIA INC 144A LIFE SR UNSEC 6.25% 06-01-32 | 6.250% | 2032-06-01 | 260 | $789.35M |
| IQVIA Inc | 5.000% | 2026-10-15 | 75 | $400.74M |
| IQVIA Inc | 5.000% | 2027-05-15 | 114 | $367.35M |
| IQVIA INC | 6.250% | 2029-02-01 | 116 | $283.45M |
| IQVIA Inc | 5.700% | 2028-05-15 | 85 | $257.99M |
| IQVIA INC | 6.500% | 2030-05-15 | 96 | $211.00M |
| IQVIA INC | 4.625% | 2033-06-15 | 2 | $4.01M |
| IQV 5.7 05/15/28 144A | 5.700% | 2028-05-15 | 1 | $0.07M |
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Go deeper in your own AI
15 years of statements, narrative and filings — queryable over MCP.
Professionals can also use the built-in AI chat (subscription + your own Anthropic key).
15 years of IQVIA HOLDINGS INC.'s financials
Income statement, balance sheet and cash flow across 15 years, every filing with its disclosures, and each number traceable to the filing it came from — free with an account, no card required.
Sign in free